Search - tctmd.com

Displaying 661 - 680 of 718

Sort: Relevancy | Date

News Daily News

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Jason Kahn

March 06, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Presentation

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

Presenter: G. Sarno

January 08, 2012

News Daily News

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Leah Lawrence

January 05, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

November 16, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

Advertisement

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Statins Reduce Late Restenosis After SES Implantation

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

DES Associated with Less Downstream Lesion Development than BMS

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Clinical Variables Added to Syntax Score Increases Predictive Ability

IVUS Guidance of DES Implantation Improves Outcomes

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content